Pharmaceutical Nanotechnology Research Lab, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.
Faculty of Pharmacy, Industrial Pharmacy Department, Alexandria University, Alexandria, Egypt.
J Drug Target. 2023 Sep;31(8):832-857. doi: 10.1080/1061186X.2023.2247583. Epub 2023 Aug 17.
Central nervous system integrity is the state of brain functioning across sensory, cognitive, emotional-social behaviors, and motor domains, allowing a person to realise his full potential. Thus, brain disorders seriously affect patients' quality of life. Efficient drug delivery to treat brain disorders remains a crucial challenge due to numerous brain barriers, particularly the blood-brain barrier (BBB), which greatly impacts the ultimate drug therapeutic efficacy. Lately, nanocarrier technology has made huge progress in overcoming these barriers by improving drug solubility, ameliorating its retention, reducing its toxicity, and targeting the encapsulated agents to different brain tissues. The current review primarily offers an overview of the different components of BBB and the progress, strategies, and contemporary applications of the nanocarriers, specifically lipid-based nanocarriers (LBNs), in treating various brain disorders.
中枢神经系统完整性是大脑在感觉、认知、情感-社会行为和运动领域发挥功能的状态,使一个人能够充分发挥其潜力。因此,脑部疾病严重影响患者的生活质量。由于存在许多脑部屏障,特别是血脑屏障(BBB),高效的药物输送来治疗脑部疾病仍然是一个关键的挑战,这极大地影响了最终的药物治疗效果。最近,纳米载体技术在克服这些障碍方面取得了巨大的进展,方法是提高药物的溶解度、改善其保留率、降低其毒性,并将封装的药物靶向不同的脑组织。本综述主要概述了 BBB 的不同组成部分以及纳米载体,特别是基于脂质的纳米载体(LBNs)在治疗各种脑部疾病方面的进展、策略和当代应用。